DeepCyte is a techbio company developing AI-driven toxicology tools for drug development. The company offers solutions to detect, predict, and explain drug toxicity in human cells at single-cell resolution, enabling biopharma teams to improve preclinical safety assessment and understand heterogeneous cellular effects.